Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy

To determine whether raltegravir-containing antiretroviral therapy (ART) intensification reduces HIV levels in the gut. Open-label study in HIV-positive adults on ART with plasma HIV RNA below 40 copies/ml. Seven HIV-positive adults received 12 weeks of ART intensification with raltegravir alone or...

Ausführliche Beschreibung